Thermo Fisher Scientific (TMO) EV to EBITDA (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported EV to EBITDA for 18 consecutive years, with 89.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EV to EBITDA rose 10.36% year-over-year to 89.0; the trailing twelve-month figure through Jun 2026 stood at 22.8 (up 14.15% YoY), and the FY2025 full-year result was 26.5, up 1.9% from the prior year.
• EV to EBITDA retreated to 89.0 in Q2 2026 per TMO's latest filing, from 92.74 in the prior quarter.
• Across five years, EV to EBITDA topped out at 140.09 in Q2 2023 and bottomed at 80.65 in Q2 2025.
• Historically, EV to EBITDA has averaged 105.1 across 5 years, with a median of 105.67 in 2023.
• The sharpest annual moves came in 2023 and 2025: EV to EBITDA surged 72.39% in 2023, then decreased 29.13% in 2025.
• Over 5 years, EV to EBITDA stood at 109.53 in 2022, then retreated by 4.26% to 104.87 in 2023, then decreased by 9.75% to 94.65 in 2024, then declined by 3.82% to 91.03 in 2025, then decreased by 2.23% to 89.0 in 2026.
• According to Business Quant data, EV to EBITDA over the past three periods registered 89.0, 92.74, and 91.03 for Q2 2026, Q1 2026, and Q4 2025 respectively.